NASDAQ:ICUI - ICU Medical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $224.59 -4.37 (-1.91 %) (As of 05/19/2019 10:24 AM ET)Previous Close$224.59Today's Range$224.4750 - $228.985052-Week Range$210.94 - $321.70Volume168,040 shsAverage Volume221,757 shsMarket Capitalization$4.63 billionP/E Ratio29.13Dividend YieldN/ABeta0.69 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation/urologics, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California. Receive ICUI News and Ratings via Email Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:ICUI Previous Symbol CUSIP44930G10 CIK883984 Webwww.icumed.com Phone949-366-2183Debt Debt-to-Equity RatioN/A Current Ratio3.86 Quick Ratio2.51Price-To-Earnings Trailing P/E Ratio29.13 Forward P/E Ratio26.27 P/E GrowthN/A Sales & Book Value Annual Sales$1.40 billion Price / Sales3.31 Cash Flow$11.8081 per share Price / Cash Flow19.02 Book Value$62.22 per share Price / Book3.61Profitability EPS (Most Recent Fiscal Year)$7.71 Net Income$28.79 million Net Margins4.04% Return on Equity13.70% Return on Assets11.06%Miscellaneous Employees8,100 Outstanding Shares20,610,000Market Cap$4.63 billion Next Earnings Date8/8/2019 (Estimated) OptionableOptionable ICU Medical (NASDAQ:ICUI) Frequently Asked Questions What is ICU Medical's stock symbol? ICU Medical trades on the NASDAQ under the ticker symbol "ICUI." How were ICU Medical's earnings last quarter? ICU Medical, Incorporated (NASDAQ:ICUI) released its quarterly earnings data on Thursday, May, 9th. The medical instruments supplier reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $1.96 by $0.39. The medical instruments supplier had revenue of $330.93 million for the quarter, compared to analyst estimates of $318.97 million. ICU Medical had a net margin of 4.04% and a return on equity of 13.70%. The business's quarterly revenue was down 11.0% compared to the same quarter last year. During the same period last year, the firm earned $2.26 earnings per share. View ICU Medical's Earnings History. When is ICU Medical's next earnings date? ICU Medical is scheduled to release their next quarterly earnings announcement on Thursday, August 8th 2019. View Earnings Estimates for ICU Medical. What guidance has ICU Medical issued on next quarter's earnings? ICU Medical issued an update on its FY 2019 earnings guidance on Thursday, February, 28th. The company provided earnings per share guidance of $9.00-9.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.40. What price target have analysts set for ICUI? 1 brokers have issued 1 year target prices for ICU Medical's stock. Their forecasts range from $300.00 to $300.00. On average, they anticipate ICU Medical's share price to reach $300.00 in the next twelve months. This suggests a possible upside of 33.6% from the stock's current price. View Analyst Price Targets for ICU Medical. What is the consensus analysts' recommendation for ICU Medical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 1 strong buy rating for the stock, resulting in a consensus recommendation of "Strong Buy." View Analyst Ratings for ICU Medical. Has ICU Medical been receiving favorable news coverage? Press coverage about ICUI stock has trended positive recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ICU Medical earned a media sentiment score of 2.2 on InfoTrie's scale. They also assigned headlines about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. Who are some of ICU Medical's key competitors? Some companies that are related to ICU Medical include ResMed (RMD), Teleflex (TFX), ABIOMED (ABMD), DexCom (DXCM), Hill-Rom (HRC), Insulet (PODD), Haemonetics (HAE), Penumbra (PEN), Novocure (NVCR), Integra Lifesciences (IART), Globus Medical (GMED), Tandem Diabetes Care (TNDM), NuVasive (NUVA), Merit Medical Systems (MMSI) and Cantel Medical (CMD). What other stocks do shareholders of ICU Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton Dickinson and (BDX), CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), UnitedHealth Group (UNH), Alibaba Group (BABA), ABIOMED (ABMD), GW Pharmaceuticals PLC- (GWPH) and Aegean Marine Petroleum Network (ANW). Who are ICU Medical's key executives? ICU Medical's management team includes the folowing people: Mr. Vivek Jain, Chairman & CEO (Age 47)Mr. Scott E. Lamb, CFO & Treasurer (Age 56)Mr. Christian B. Voigtlander, Chief Operating Officer (Age 51)Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel & Sec. (Age 44)Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 61) Who are ICU Medical's major shareholders? ICU Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Janus Henderson Group PLC (13.04%), BlackRock Inc. (7.21%), JPMorgan Chase & Co. (2.51%), FMR LLC (2.03%), AQR Capital Management LLC (1.72%) and Wells Fargo & Company MN (1.44%). Company insiders that own ICU Medical stock include Alison D Burcar, Christian B Voigtlander, Daniel Woolson, George A Lopez, Joseph R Saucedo, Pfizer Inc, Robert S Swinney, Scott E Lamb, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain. View Institutional Ownership Trends for ICU Medical. Which institutional investors are selling ICU Medical stock? ICUI stock was sold by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Wells Fargo & Company MN, Marshall Wace LLP, Bank of Montreal Can, Voya Investment Management LLC, AQR Capital Management LLC, SG Americas Securities LLC and Marshall Wace North America L.P.. Company insiders that have sold ICU Medical company stock in the last year include Alison D Burcar, Christian B Voigtlander, Daniel Woolson, George A Lopez, Pfizer Inc, Robert S Swinney, Thomas D Mccall and Virginia Ruth Sanzone. View Insider Buying and Selling for ICU Medical. Which institutional investors are buying ICU Medical stock? ICUI stock was bought by a variety of institutional investors in the last quarter, including Lazard Asset Management LLC, AMI Asset Management Corp, Janus Henderson Group PLC, Federated Investors Inc. PA, Northern Trust Corp, BlackRock Inc., Wellington Management Group LLP and Raymond James & Associates. View Insider Buying and Selling for ICU Medical. How do I buy shares of ICU Medical? Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is ICU Medical's stock price today? One share of ICUI stock can currently be purchased for approximately $224.59. How big of a company is ICU Medical? ICU Medical has a market capitalization of $4.63 billion and generates $1.40 billion in revenue each year. The medical instruments supplier earns $28.79 million in net income (profit) each year or $7.71 on an earnings per share basis. ICU Medical employs 8,100 workers across the globe. What is ICU Medical's official website? The official website for ICU Medical is http://www.icumed.com. How can I contact ICU Medical? ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected] MarketBeat Community Rating for ICU Medical (NASDAQ ICUI)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 285 (Vote Outperform)Underperform Votes: 286 (Vote Underperform)Total Votes: 571MarketBeat's community ratings are surveys of what our community members think about ICU Medical and other stocks. Vote "Outperform" if you believe ICUI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICUI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: Why are gap-down stocks important? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.